Biomedical research: Drug hunters wanted
A newly approved class of anti-cholesterol medications could be the latest in a long line of ‘biopharmaceutical blockbusters’. These drugs not only produce big revenue for pharmaceutical companies, but also represent employment opportunities for early-career scientists who want to develop cutting-edge therapies. To get into the game, aspiring young researchers must tailor their training and skills to the industry… Read more at Nature.
Biotechnically Speaking 